| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Spartha Medical the active interfaces We develop the first range of versatile and customisable active interfaces with sustainable formulations. We use supramolecular chemistry and biopolymers to produce the first-in-class protective kit, protect|ION, to help patients and medical staff with wound healing to fight antibiotic resistance and hospital-acquired infections. Our customised spartha|SHIELD service offering and its SHIELD+ extension enable innovative and safe products to be developed by integrating our technologies through codevelopment, in the medical device, cosmetics, electronics and textile sectors. Coatings, Antimicrobial, Medical Devices, Implants, Polymers, Biomaterials, Anti-inflammatory, Nanotechnology, and Personalised Medicine Type: | 16 | 6 | 13 | 27 |
 | Abbelight [Automatic translation follows] From Microscopy to Nanoscopy _ Scalable bioimaging solutions and multiple expertise to speed-up your imaging projects Founded in 2016, Abbelight is a fast-growing company specialized in imaging solutions focusing on microscopy and unique single molecule detection (super-resolution). The portfolio integrates a constantly evolving knowhow on chemistry, optics and computer science to offer a complete solution, from sample preparation to data management, including an optimal bio-imaging platform that can be adapted to all researchers', biotech labs' and medical facilities' needs. Abbelight is a French company developed by four passionate researchers who aim to help improve human health in … Type: | 12 | 6 | 8 | 51 |
 |  Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: | 7 | 6 | 3 | 11 |
 | Advanced BioDesign Overcoming Tumor Drug Resistance Founded in 2010, Advanced BioDesign is a clinical stage company developing a highly promising therapy for cancer with high unmet medical needs. Advanced Biodesign has developed a therapeutic approach based on a selective inhibition of ALDH enzymes. Advanced Biodesign project consist in the development of small-molecule that will selectively inhibit specific ALDH enzyme. By targeting this family of enzyme, will block specifically the intracellular mechanism of detoxification that cancerous cells have developed in order to escape form the programmed cell death called apoptosis. Oncology Type: | 5 | 1 | 4 | 22 |
 |  INOVACTIS [Automatic translation follows] A versatile immunotherapy for personalized cancer medicine Inovactis is developing an innovative treatment against cancer at the frontier between several ongoing revolutions: individualized medicine, immunotherapy and synthetic biology. immunotherapy and personalized medicine Type: | 1 | 0 | 0 | 1 |
 | NOVAPTECH The Aptamer Expert Company Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects. Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies. Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has more than 26 years of experience in aptamer selection. Research and Development and Therapeutics and Diagnostics Type: | 3 | 3 | 1 | 10 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 9 | 5 | 5 | 81 |
 | NFL BIOSCIENCES Two Simple Injections for Total Smoking Cessation NFL BIOSCIENCES clinically develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. It is delivered via two simple subcutaneous injections, administered one week apart, making patient compliance a breeze. There exists vast anecdotal evidence, from more than 10,000 smokers treated off-label in France with a predecessor product developed by the Pasteur Institute, that NFL-101 is safe and efficacious for total smoking cessation at twelve months. A Phase 1 clinical trial that reported data in 2017 confirmed safety and efficacy in smokers willing … Type: | 0 | 0 | 0 | 8 |
 | Carmat Their life. Your skills. Our technology. CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic … Type: | 6 | 0 | 4 | 764 |
 |  ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 30 | 15 | 19 | 56 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 20 | 6 | 17 | 86 |
 | Valerio Therapeutics Valerio is a clinical-stage biotechnology company developing novel oncology drugs targeting tumor DNA-binding functions. Valerio Therapeutics is a clinical-stage biotechnology company based in France and the US that develops new drugs by targeting tumor DNA functions through unique mechanisms of action in the field of DNA Damage Response (DDR). DDR consists of a network of cellular pathways that detect, report and repair DNA damage. Applied to oncology, this new field of research aims to weaken or block the ability of tumor cells to repair damage to their DNA, either naturally or under the effect of cytotoxic treatments. Focusing exclusively on … Type: | 1 | 1 | 0 | 64 |
 | Valneva Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. … Type: | 23 | 10 | 6 | 654 |
 | BILHI Genetics The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases. To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands … Type: | 1 | 1 | 1 | 5 |
 | E>Swin [Automatic translation follows] E-Swin is a French company founded and managed by Yves Vincent BROTTIER that designs, manufactures and markets high-tech light products, all of which are medically certified. In 2007, E>Swin developed and marketed the E>One, the first professional personal epilator with a flash lamp. This high-tech device allows individuals to access a patented technology that was previously reserved for beauty and health professionals. Our research laboratory and production unit based in Yvelines allow us to innovate by working on other applications of pulsed light: dermatology (acne, pigment spots), aesthetics (anti-aging) and medical (ophthalmology). The E>Eye is the only … Type: | 0 | 0 | 0 | 23 |
 | NeoMedLight The Caring Light NeoMedLight develops innovative medical devices designed for phototherapy. The company owns a unique and exclusive technology: the emission of light through woven optical fibers: the Lightex®. NeoMedLight is committed to the treatment and prevention of oral mucositis and radiodermatitis, a huge unmet clinical need. Mucositis and radiodermatitis are the most common and debilitating side effects of chemotherapy and radiotherapy reported by cancer patients. CareMin650TM is an innovative solution leveraging our innovative Lightex® technology indicated for the prevention and treatment of mucositis and dermatitis in cancer patients. The CareMin650TM system allows patients to be treated safely, with precise … Type: | 3 | 1 | 1 | 9 |
 | Alvéole Bioengineering unleashed! Tools for better cell sample preparation: better cell models for cell biology and microscopy. Created from work carried out by three research experts, Alvéole’s goal is to make the control of living cells the future of cell biology. A company specialized in devices for controlling the cellular microenvironment, Alvéole presents its first device PRIMO. Alvéole was founded in 2010 by three researchers from CNRS* in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products. Vincent Studer (a specialist in bio-engineering), Maxime Dahan … Type: | 7 | 0 | 7 | 14 |
 | myaddie My Addie creates digital solutions that help people live with their addictions on a daily basis. Addiction is a reality that reaches out everyone, from sugar to drugs, from sports to shopping, nowadays, we are all addicted to something, and.. that's fine. The question is, what do we do about it ? This is why we at My Addie have created a unique methodolgy created by an addict, for addicts, backed up by the latest neuroscience, and a solid team of therapists. My addie strongly believes that it is time to put people back at the center of their journeys, … Type: | 3 | 1 | 2 | 2 |
 | ManRos Therapeutics From Sea to Pharmacy ManRos Therapeutics is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors for the treatment of cystic fibrosis. ManRos was founded in 2007 and is led by Dr Laurent MEIJER, Chairman and CSO, former distinguished Director of Research at the CNRS, and Dr Philippe de Lavenne, CEO, former Vice-President at Actelion Pharmaceuticals. For 40 years, Dr Meijer dedicated his research to the study of protein kinases and their inhibitors, mostly at the CNRS. Drug Development, Cystic Fibrosis, and Biotechnology Type: | 2 | 2 | 0 | 5 |
 | Thabor Therapeutics Develops innovative treatments for mucosal inflammatory diseases Thabor's website Type: | 1 | 0 | 0 | 11 |
 | ABC transfer Ultraclean Sterile Transfer Solutions For The Global Pharmaceutical Industry ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the pharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria resolving customers’ challenges worldwide. Led by an executive team of pharma transfer solution experts with decades … Type: | 0 | 0 | 0 | 14 |
 | Roca Therapeutics A united team creating an innovative therapy to give a new life / vision to patients First In Class Drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation Cancer treatment, Eye disease, Angiogenesis, Inflammation, Drug development, and Personalized therapy Type: | 11 | 4 | 5 | 6 |
 | Meccellis Biotech French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and … Type: | 8 | 1 | 2 | 10 |
 | WhiteLab Genomics Unleash the Potential Of Genomic Medicine Using AI Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development timelines and mitigate associated risks. Based on exhaustive datasets, the platform provides in-silico simulations to discover, and design optimized payloads and vectors. WhiteLab aims to expedite the drug development process, cut costs, and accelerate the delivery of life-saving therapies to the market. The company collaborates with leading pharmaceutical companies such … Tags: FrenchTech2030 Type: | 43 | 15 | 32 | 43 |
 | Standing Ovation Where the wonders of fermentation meet science. Standing Ovation is a French protein company specializing in precision fermentation. The company has developed its first patented ingredient, Advanced Casein®, which is produced with 10 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, functional and taste qualities on par with the animal-sourced protein. Standing Ovation will launch its flagship protein in the United States in 2025 and aims to be a global leader in the food and environmental transition. As a winner of the French Tech 2030 program, Standing Ovation has received government … Tags: FrenchTech2030 Type: | 34 | 9 | 26 | 38 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. Type: | 2 | 2 | 0 | 9 |
 | Ciloa SAS Inspired by Exosomes CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high-potential bio-drugs. By overcoming undruggable targets, Ciloa supports your projects to create new therapeutic and new preventive solutions. Ciloa customizes in vivo exosomes to contain i) fully native membrane protein complexes (GPCRs, Kinase Receptors, Ion Channels, Viral Antigens, Transporters...) embedded in their membrane and ii) chosen cargo proteins inside their cytosol. Natural properties of exosomes combined with Ciloa in vivo disruptive technology allow to develop: - VIRUS-FREE candidate THERAPEUTIC VECTORS able to deliver specifically chosen cargos to … Type: | 3 | 3 | 0 | 10 |
 | POLYGON Therapeutics Innovation. Applied. Bringing life to life. POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches. Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular diseases care. Type: | 13 | 6 | 10 | 9 |
 | Vaxxel The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin Type: | 6 | 0 | 6 | 11 |
 | Ermium Therapeutics Controlling auto-immune diseases Ermium Therapeutics is a discovery stage Biotechnology company developping innovative therapies for auto-immune diseases Type: | 2 | 2 | 0 | 6 |
 | Jalon Therapeutics Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Our mission is to develop medicines that will transform the lives of people fighting cancer. For that purpose, we leverage our deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. This mechanism, defined as “non-oncogene addiction” (NOA), offers potential novel, safer and more effective therapeutic strategies. Jalon Therapeutics is rooted in pioneering fundamental research and clinical investigations from INSERM laboratories … Type: | 1 | 1 | 0 | 3 |
 | Brenus Pharma New generation of precision medicine in oncology with proprietary STC platform designed to generate cancer-vaccines 🧬🟣 We are building a company with a bold ambition to become a leader in cancer vaccines, making patients active participants in their own fight against cancer. Cancer is an evolving target that constantly adapts to escape the immune system and resist to treatment. Given this high unmet need, we developed a tech-platform generating new therapeutic vaccines against cancer, called STC for ‘Stimulated-Tumor-(ghost)-Cells’. STC mimics, in the laboratory, the relapse conditions of patients' tumor cells to educate their immune systems to be able to anticipate, … Type: | 26 | 9 | 13 | 18 |
 | LinKinVax LinKinVax aims at creating a universal, safe, enduring, vaccines platform against multiple pathogens. We are a clinical stage Biotech Spin-off of the Vaccine Research Institute in France with a unique "DC targeting" platform covering infectious desaeses and oncology. Type: | 11 | 0 | 11 | 5 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 15 | 5 | 11 | 68 |
 | BiPER Therapeutics First in class small molecules pushing cancer cells to burn out BiPER Therapeutics is developing a first-in-class pipeline of therapeutics overstressing cells to cure patients. The company’s lead compound, BPR001, is a first-in-class small molecule therapeutic targeting BiP, an oncogenic protein shown to have a critical role in cancer Type: | 10 | 6 | 9 | 7 |
 | Immusmol Immusmol develops small molecule antibodies for research, diagnostics and therapy. Combining 25 years of experience in antigen design, we offer to target low molecular weight molecules, which are not usually addressed by antibodies, such as amino acid metabolites, lipids, saccharids, toxins, pesticide residues, small molecule drugs, ... Compatible with existing antibody-based technologies, our small molecule antibodies can serve for: > VISUALIZATION: Small molecule antibodies currently represent the only applicable technology for the visualization of small molecules in cells and tissues by IF or IHC. > QUANTIFICATION: Combined with ELISA/EIA technologies, small molecule antibodies enable rapid and robust detection of small … Type: | 1 | 1 | 0 | 10 |
 | INOVOTION Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy … Type: | 16 | 7 | 10 | 19 |
 | Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production … Type: | 3 | 0 | 3 | 1 |
 | EUROPE TECHNOLOGIES Services and Innovations for your Industrial Processes With more than 25 years of experience, Europe Technologies group offers you its expertise for : • #Industrialization and manufacturing of composite and metallic parts • Design and #manufacturing of robot cells and machines around our processes (metal surface treatment, composite welding, cutting, sanding, acoustic drilling...) • International #MRO services (airplanes, vessels, ...) We support our customers from R&D to industrialization of parts and processes. We are serving all industries where innovations and reliables processes are needed : Aeronautics, Naval, Defense, Energy, Automotive & Transportation, Medical & Cosmetics, Food-Industry... Subsidiaries part of Europe … Type: | 21 | 9 | 9 | 109 |
 | ALSACHIM SAS Your strategic supplier for stable isotope-labeled internal standards Created in 2005, Alsachim is one of the world leaders in the synthesis of stable labeled (13C, 2H, 15N, 34S, 18O) internal standards, used in bioanalysis studies, chemicals, building blocks and metabolites. Based on its expertise, Alsachim develops also Therapeutic Drug Monitoring devices to support hospitals and bioanalyse center to their daily work and routine operation. We supply our products to customers all over the world, spread across the chemical discipline including the pharmaceutical and biotech industry, clinical and bio-analytical CROs, and research institutions, in areas such as Health, Food and Environment. … Type: | 2 | 2 | 0 | 48 |
 | AFFICHEM [Automatic translation follows] Affichem is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: | 1 | 1 | 0 | 1 |
 | HAcare - Medical Furniture French designer and manufacturer of medical devices since 1955 Allibert Medical, Corona Medical and Sotec Medical unite to form the HAcare group. By relying on the know-how of our brands, and the expertise of our teams, we can support you in the choice and installation of medical equipment (medical bed, ambulatory chair, stretcher, etc.), the management of the medication circuit (trolley, cupboard, etc.), home support and fitting out of common living areas (bedside table, dining table, bridge, etc.). lit médicalisé, mobilier modulaire, maintien à domicile, fauteuil ambulatoire, projet global, and accompagnement Type: | 1 | 1 | 1 | 78 |
 | Interrupt Biomedical and Engineering Inc. health technologies for everyone Interrupt Engineering is a medical device company known for its innovative products, including MoveMate, a wearable health technology designed to detect freezing of gait, a movement disorder commonly seen in Parkinson's patients. biyomedikal, elektronik, and medikal cihaz Type: | 0 | 0 | 0 | 7 |
 | Rethink Medical SL. Rethink Medical S.L. is a start-up company dedicated to the development of new medical devices in the nursing field. Rethink Medical is a Spanish startup company focused on developing innovative medical devices, mainly in the nursing field, based on real life experiences regarding both patient needs and common hospital procedures. Our first patented product is a urinary catheter We are working on other continence-related projects as well, improving healthcare processes and patient comfort due to the aging of the population and the increased need for these products. Type: | 0 | 0 | 0 | 6 |
 | Remma [Automatic translation follows] 1st marketplace for used medical devices for professionals. 1st marketplace specializing in the sale and reconditioning of used medical devices for healthcare professionals. Type: | 1 | 0 | 0 | 10 |
 | Probably Genetic Helping people with rare genetic diseases get answers. Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested … Type: | 0 | 0 | 0 | 31 |
 | Octarine Bio We're harnessing nature to drive sustainable solutions Pioneering new sustainable bio-based ingredients Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering Type: | 1 | 1 | 0 | 27 |
 | Mondarella Plant-based cheese redefined. Super tasty, clean label, high nutritional value - cheese craft meets bio-tech. Mondarella Homepage plant-based cheese, vegan cheese, food-tech, food bio-tech, food innovation, plant-based, cheese , startup, and alternative protein Type: | 1 | 0 | 0 | 30 |
 | Cellevate AB Innovative biotech company developing next generation of cell culture systems designed to revolutionize biomanufacturing Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3dTM - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3dTM carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform … Type: | 1 | 0 | 1 | 26 |
 | Lytix Biopharma A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel therapy to fight cancer. Lytix Biopharma is a clinical-stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. Lead compound LTX-315 provides access to antigens by using the patient’s own tumor as source of antigens and turns cold tumors hot. Local treatment with LTX-315 targets the first step in the cancer immunity cycle with a potential cornerstone position in immunotherapy. Type: | 0 | 0 | 0 | 18 |
 | SERio Roślinny ser Pierwszy na świecie roślinny ser z łubinu! Bogaty w białko, naturalne składniki, narodzony z pasji do roślinnej kuchni. World's first plant-based cheese made from the lupine bean. Rich in protein, clean label and real taste is what is most important to us! We are people with passion and we want to change the world by offering new possibilities and amazing food. Type: | 1 | 0 | 1 | 4 |
 | Tessellate BIO Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology Type: | 0 | 0 | 0 | 25 |
 | Cirdan Ltd Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered … Type: | 3 | 0 | 2 | 99 |
 | Egetis Therapeutics AB Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment Type: | 0 | 0 | 0 | 47 |
 | Laminar Pharma Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs. Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the … Type: | 1 | 0 | 1 | 33 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: | 0 | 0 | 0 | 13 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 3 | 15 |
 | ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: | 1 | 0 | 0 | 17 |
 | Synerkine Pharma Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands. Type: | 1 | 0 | 1 | 8 |
 | TrackPaw Scientific AB We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R Type: | 1 | 0 | 1 | 10 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. Type: | 4 | 0 | 0 | 6 |
 | X-Bolt Orthopedics "Simplicity, the ultimate sophistication" (Leonardo da Vinci) X-Bolt brings simplicity and efficiency to trauma surgery, whilst improving quality of life for patients. surgery, orthopedics, medical devices, distribution, hip trauma, sales, marketing, and design Type: | 0 | 0 | 0 | 13 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: | 0 | 0 | 0 | 57 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … Type: | 0 | 0 | 0 | 175 |
 | HeartBeat.bio AG REINVENTING CARDIAC DRUG DISCOVERY HeartBeat.bio (HBB) is an emerging TechBio company developing a next-generation drug discovery platform for heart diseases. Our so-called Cardioid Drug Discovery Platform is based on a proprietary iPSC-derived single and multi-chamber cardiac organoid model. We combine this unique human biology with state-of-the-art hardware solutions to industrialize the organoid cultivation and screening process as well as AI-supported software for high-content and big data analysis. HBB pursues an end-to-end human-centric drug discovery approach along the entire pre-clinical value chain: Starting with target identification and validation, disease modeling, hit identification and confirmation, leading up to compound development and profiling … Type: | 0 | 0 | 0 | 22 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: | 0 | 0 | 0 | 15 |
 | Pixelgen Technologies Pioneering Spatial Proteomics for Single Cells Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships. Life operates by the spatial orchestration of proteins and at Pixelgen we have developed Molecular Pixelation that analyses cell surface proteins in a completely new way. Using current technologies, there are limitations of light and taking images influencing how many proteins and how many samples that can be analysed concurrently. With molecular … Type: | 0 | 0 | 0 | 29 |
 | Da Volterra Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives. Committed to innovation, Da Volterra develops products intended to protect the intestinal … Type: | 5 | 2 | 2 | 7 |
 | ulrich medical dedicated to you. ulrich medical develops, produces and markets innovative medical technology. Founded in 1912, this year we celebrate our 112th anniversary. Physicians and users worldwide trust in our many years of experience. With product divisions in spinal implants and contrast media injectors for CT and MRI, we offer a comprehensive portfolio of innovative products. We are one of the few in the industry with development and production in Germany and we rely on the most modern manufacturing technology. Our products stand worldwide for the highest degree of quality "Made in Germany". We employ more than 600 employees internationally. And … Type: | 1 | 0 | 1 | 324 |
 | Eurofins Advinus Preferred Partner for Discovery and Development Services Eurofins Advinus Private Limited is a premier contract research, development and manufacturing organization (CRDMO) serving diverse industries to help advance their R&D programs within defined timelines with highest level of quality. With 30+ years of GLP experience, we have a proven track record of successfully delivering many integrated and stand-alone projects to meet our partner’s requirements. We offer a complete suite of drug discovery and development services. Our drug discovery services include medicinal and synthetic chemistry, ADMET/DMPK and Discovery Biology across various therapeutic areas. Our preclinical development services include process development, DMPK and … Type: | 1 | 1 | 1 | 892 |
 | CareDx, Inc. Dedicated to transplant patients. Leading with innovation. CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure … Type: | 2 | 0 | 1 | 682 |
 | bioWORLD Molecular Tools and Laboratory Essentials Since its founding in 1992, bioWORLD has established, maintained, and succeeded in its core mission to manufacture and supply high-quality molecular tools, biological reagents, and laboratory supplies to analytical laboratories, academia institutions, and research corporations globally. bioWORLD specializes in numerous product lines for the Life Sciences and Biotechnology industries. With product focuses including bioAffinity reagents for protein purification and proteomics research, recombinant proteins and synthetic peptides, plant, microbiological, animal, and yeast media, and many other fields. In addition, bioWORLD offers services including custom peptide synthesis and antibody production. The company's headquarters are in Dublin, Ohio, … Type: | 0 | 0 | 0 | 38 |
 | Arterra Bioscience S.p.A. We care about everybody's health Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers. Biotechnology, R&D, Cosmetics, medical Device, Agriculture, and Agrifood Type: | 2 | 2 | 0 | 40 |
 | Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … Type: | 15 | 2 | 13 | 81 |
 | CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: | 12 | 5 | 7 | 2 |
 | Proteus by Seqens Biocatalysis from Lab to Industrial Scale Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals … Type: | 1 | 0 | 1 | 24 |
 | PROMETHEE - Hépatites [Automatic translation follows] Hepatitis in the Alpine Arc (38,73,74) Prevention and screening of viral hepatitis and liver diseases. PROMETHEE Hepatitis in the Alpine Arc (Isère, Savoie, Haute Savoie) Health association created in 1999, part of the MRSI. Service for the prevention, awareness, screening of viral hepatitis and any other liver disease. Free awareness-raising for at-risk or specific audiences, the general public and professionals. Prevention and screening permanences with a diagnostic orientation (via TROD and FIBROSCAN®) with partners for their audiences. Organization of the Hepatitis Day in the Alpine Arc (information actions, screening in collaboration with the analysis laboratories and the … Type: | 2 | 0 | 0 | 4 |
 | Nextep Health Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” … Type: | 19 | 3 | 16 | 49 |
 | Wavepaths Music technology responsive to who you are and how you feel. Designed for therapeutic work. linktr.ee/wavepaths Wavepaths unifies immersive arts, psychotherapies and intelligent technologies into a new approach to well-being. Music, Art, Intelligent Technologies, Psychedelic Medicine, and Therapeutic Type: | 1 | 1 | 0 | 12 |
 | AgGene Developing technology for tomorrow's crops AgGene is an agriculture biotechnology company focused on the development of plant traits to address major challenges faced during crop production. Our flagship technology addresses the demand for improving protein content in plant tissues using advanced genomics and molecular plant breeding techniques including gene-editing. AgGene is also focused on collaborative relationships with other agriculture companies and independent plant breeders to help develop plant biotech traits to address issues including climate resilience. biotechnology, gene editing, agriculture, molecular genetics, molecular biology, genomics, genetic engineering, and plant biology Type: | 2 | 2 | 0 | 4 |
 | Hesperos Inc. The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the … Type: | 2 | 0 | 2 | 62 |
 | DermTech, LLC DermTech, LLC provides genomic analysis of skin samples collected non-invasively using its Smart Stickers. DermTech develops and markets products to facilitate the assessment of melanoma. Melanoma, Gene Expression Testing, Pigmented Lesions, Dermatology, and Dermatopathology Type: | 1 | 0 | 0 | 104 |
 | Animal-Free Safety Assessment Collaboration The AFSA Collaboration works to accelerate the adoption of modern, human-relevant approaches to testing. The Animal-Free Safety Assessment (AFSA) Collaboration is a unique multi-sector partnership between non-profit, corporate, and philanthropic leaders working to advance acceptance and use of animal-free safety science as a gold standard across regulatory frameworks worldwide. AFSA brings together corporate, philanthropic and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing. Our members cooperate on a range of educational and policy topics specific to the cosmetics, … Type: | 9 | 1 | 9 | 1 |
 | Synthesea Building a biological platform to produce low-cost, sustainable omega-3 for aquaculture. Powered by Synthetic Biology. Powered by Synthetic Biology, Synthesea is developing synthesis technology that is transferable to a wide range of lipids (AKA fats). And we're starting with omega-3. Omega-3 oil is a necessity for fish to grow nutritiously and is naturally found in algae, which wild fish eat. Fish grown in aquaculture (farms for fish livestock) cannot eat algae due to scaling limitations. Therefore, the current solution is to feed wild-caught fishmeal (crushed fish) to aquaculture fish. This rapidly depletes wild fish stocks and is continuously increasing the … Type: | 0 | 0 | 0 | 1 |
 | AQUA Cultured Foods Indulge your seafood cravings, without the catch. 🎣 Eat your heart out. AQUA makes seafood safe again. Fins down, AQUA is earth’s most exciting fermentation-enabled fiber. While AQUA seafood looks like fish, tastes like fish, and feels like fish––it's 100% fish-free. We hyper-control the growing environment so every morsel of tuna, scallop, squid, and shellfish is flawless––and forever available to feed billions of seafoodies. alternative meat, alternative seafood, alternative protein, food tech, biotech, fermentation, and sustainability Type: | 4 | 2 | 3 | 19 |
 | Elite Sweets Elite Sweets is on a mission to redefine sweets. We make delicious protein packed donuts that are low sugar and keto 🍩 Elite Sweets is makers of The Elite Donut- A protein packed, low sugar donut, that is keto friendly, gluten free, soy free and absolutely delicious. Consumer Packaged Goods Type: | 2 | 1 | 1 | 22 |
 | Nextbiotics Nextbiotics, engineering viruses for good. Biotech, CRISPR, and Digital Biology Type: | 1 | 1 | 0 | 3 |
 | Next Big Innovation Labs® Next Big Innovation Labs® is a Deep Tech Lifesciences platform, developing 3D Bioprinting Technology and Products Next Big Innovations Labs (NBIL) is a startup of enthusiastic individuals on a mission to confront the world’s most challenging problems in the healthcare space. We are a research driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. We feel we can crack these problems only by using the disruptive technology of 3D Bioprinting. At NBIL, we focus to solve the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to … Type: | 4 | 1 | 3 | 30 |
 | Ludocare Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions. Created in 2017 in Lyon, Ludocare develops evidence-based digital therapies for the benefit of patients, those around them and healthcare professionals. ✅ Its objective: better control of the disease and stabilization of basic treatment, to improve the quality of life of children with chronic illnesses. 💡The medical purpose of JOE digital therapy is to improve asthma control through better use of inhalation devices and increased compliance with drug treatments, and thus preventively reduce attacks and exacerbations. ➡️ To date, Ludocare is part of a scientific approach … Type: | 25 | 8 | 22 | 9 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 27 | 8 | 22 | 14 |
 | OSE Immunotherapeutics Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing … Type: | 15 | 8 | 6 | 74 |
 | AnyGenes® Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by … Type: | 0 | 0 | 0 | 6 |
 | ANAQUANT Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary … Type: | 2 | 1 | 2 | 8 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … Type: | 11 | 3 | 9 | 6 |
 | CLEAN BIOLOGICS Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance Type: | 14 | 8 | 11 | 11 |
 | IMODI Cancer Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer Type: | 1 | 0 | 0 | N/A |
 | KCAS Bio - Lyon Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. … Type: | 2 | 1 | 2 | 31 |
 | LXRepair 2013-2023 2013-2023 In a context where the rate of cancer treatment failure is still unacceptably high, our mission is to provide decision aids to oncologists. We believe that profiling is key to predicting treatment toxicity to patients and effectiveness on tumors. Over a decade of research by the French Atomic Energy Commission (CEA) on the impact of radiations on DNA has resulted in a deep understanding of the essential DNA repair mechanisms. More recently, a set of innovative biomarkers was developed that provides a complete functional signature of these mechanisms, the premise to powerful tools for personalized treatment of cancer. http://www.lxrepair.com … Type: | 3 | 1 | 2 | 3 |
 | MAG4HEALTH Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging Type: | 5 | 4 | 3 | 18 |
 | AUROBAC THERAPEUTICS Developing precision medicines to combat bacterial infections, AMR, and their consequences in acute care settings. AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines to combat bacterial infections, Antimicrobial Resistance (AMR), and their consequences in acute care settings. AUROBAC’s R&D strategy addresses these unmet medical needs with patient- and pathogen-targeted programs designed to tackle both the causes and consequences of potentially life-threatening bacterial infections and AMR, including hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) and sepsis. Central to … Type: | 4 | 1 | 3 | 23 |
Startup